Eric Boutin is a serial entrepreneur, investor, and digital health executive who has built, led, and backed companies across healthcare AI, life sciences, and consumer technology. Through Harvard Street Advising, he supports early-stage founders in launching and scaling science- and technology-driven ventures.
Previously, Eric was Venture Chair at Redesign Health, where he created and financed digital health startups. He also served as Managing Director at dRx Capital, Novartis’s digital health venture fund, leading investments in patient care, pharma tech, and healthcare AI platforms. Earlier in his career, Eric was Founder & CEO of Evolve, an AI-powered consumer tech company acquired by HubSpot (NYSE: HUBS), and Founder & CEO of Good Start Genetics, a genomics company acquired by Invitae (NYSE: NVTA). He also helped launch Flex Pharma at Longwood Fund, which went public (NASDAQ: FLKS).
He holds an MBA from Harvard Business School and a BA in Economics from Duke University. Eric has held board roles with companies from Seed to Series D, spanning digital health, life sciences, and consumer technology.
Can help with
Why Book Time with Eric?
Eric offers practical guidance on:
Fundraising and capital strategy — navigating Seed through Series B, pitching to VCs and strategics, and structuring the right deal
Go-to-market execution — designing strategies that move from MVP to market traction in health tech and enterprise SaaS
Customer discovery — refining value propositions and validating early product-market fit
Co-founder dynamics and team building — structuring founder teams and boards to support long-term growth
Exit readiness — positioning your venture for acquisition or IPO
